サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423202

バイオプリザベーション市場レポート：製品タイプ、用途、地域別、2024年～2032年

Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 145 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
バイオプリザベーション市場レポート：製品タイプ、用途、地域別、2024年～2032年
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオプリザベーション市場規模は2023年に77億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて10.4%の成長率（CAGR）を示し、2032年までに193億米ドルに達すると予測しています。大衆の間で個別化医療への関心が高まっていること、研究開発（R&D）活動への投資が増加していること、希少疾患に対する認識と理解が高まっていることが、市場を推進している主な要因の一部です。

バイオプリザベーションとは、細胞、組織、臓器、生物全体などの生物学的物質を、生存可能かつ機能的な状態で長期間保存するプロセスを指します。このプロセスの目的は、生物材料の完全性、生存能力、機能性を維持し、研究、臨床応用、工業プロセスなど様々な目的での保存、輸送、利用を可能にすることです。移植、再生医療、医薬品開発のための細胞、組織、臓器の保存を可能にするため、医療、バイオテクノロジー、研究など様々な分野で数多くの用途があります。

世界市場の主な原動力は、大衆の間で個別化医療への関心が高まっていることです。さらに、ライフサイエンス、バイオテクノロジー、ヘルスケアの分野で、政府、学術機関、民間組織による研究開発（R&D）活動への投資が増加していることも、市場を後押ししています。さらに、個人の間で希少疾患や遺伝性疾患に対する認識や理解が高まっていることから、罹患者の生物学的サンプルを保存する必要性が高まっています。これらの技術は、疾患メカニズムの研究、診断法の開発、標的療法の開発を促進するためのサンプルの収集と保存をサポートし、世界レベルでの需要に貢献しています。さらに、改良された凍結保護剤、自動化システム、強化された保存プロトコルの開拓は、保存された生物試料の効率性、信頼性、安全性の維持に役立つため、バイオプリザベーションの能力と応用を拡大し、市場の見通しをさらに明るいものにしています。

バイオプリザベーション市場の動向と促進要因：

バイオバンキング需要の増加

バイオバンク需要の増加は世界市場に大きな影響を与えています。バイオバンクとは、研究や診断の目的で、細胞、組織、血液、DNA、その他の生体物質を含む様々な生物学的サンプルを保管する貯蔵庫です。これらのサンプルの完全性、生存可能性、機能性を維持し、長期保存と使用可能性を確保する上で、これらの技術は極めて重要な役割を果たしています。大規模な集団ベースの研究、臨床試験、多様で保存状態の良い生物学的サンプルへのアクセスを必要とする研究プロジェクトに対するニーズの高まりが、世界全体のバイオバンク分野に影響を与えています。さらに、精密医療や個別化ヘルスケアへの注目の高まりは、ゲノム検査、バイオマーカー探索、個別化治療の開発に使用できるサンプルの包括的なコレクションを提供するバイオバンクの重要性を高めています。

再生医療の絶え間ない進歩

再生医療の進歩は世界市場に大きな影響を与えています。再生医療は、細胞ベースの治療法、組織工学、およびその他の革新的なアプローチを用いて、損傷した組織や臓器を回復または置換することを目的としているため、生体保存は、細胞、組織、および人工構築物の生存能力と機能性を維持することにより、再生医療の成功に重要な役割を果たしています。さらに、これらの技術は、保存や輸送中に幹細胞の生存能力や効力を維持するために不可欠です。凍結やガラス化といった凍結保存法は、幹細胞を将来の治療や研究に使用するために保存するために一般的に用いられています。幹細胞保存プロトコールや凍結保護剤の進歩により、幹細胞の生存能力や解凍後の機能性が向上し、市場の成長に寄与しています。

バイオ医薬品産業の拡大

バイオ医薬品産業の拡大は、市場に大きな影響を与える要因です。バイオ医薬品産業は、治療用タンパク質、抗体、ワクチン、細胞ベース療法を含む生物学的薬剤の開発と生産に焦点を当てています。バイオプリザベーションは、開発から流通までのライフサイクルを通じて、これらの複雑な生物学的製剤の安定性、品質、完全性を確保する上で重要な役割を果たしています。生物学的製剤は、温度、光、湿気などの環境条件に非常に敏感であるため、保存や輸送中の安定性と品質の維持に不可欠な技術として、その需要が大幅に増加しています。凍結保存、凍結乾燥、その他の適切な保存方法を採用することで、バイオ医薬品企業は製品の保存期間を延長し、患者に投与する際の有効性と安全性を確保することができます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のバイオプリザベーション市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場内訳：製品タイプ別
  • 市場内訳：用途別
  • 市場内訳：地域別
  • 市場予測
  • SWOT分析
    • 概要
    • 強み
    • 弱み
    • 機会
    • 脅威
  • バリューチェーン分析
  • ポーターのファイブフォース分析
    • 概要
    • 買い手の交渉力
    • 供給企業の交渉力
    • 競合の程度
    • 新規参入業者の脅威
    • 代替品の脅威

第6章 市場内訳：製品タイプ別

  • 生体保存機器
    • 市場動向
    • 市場予測
  • バイオプリザベーション媒体
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 治療用途
    • 市場動向
    • 市場予測
  • バイオバンク用途
    • 市場動向
    • 市場予測
  • 創薬用途
    • 市場動向
    • 市場予測

第8章 市場内訳：地域別

  • 北米
    • 市場動向
    • 市場予測
  • 欧州
    • 市場動向
    • 市場予測
  • アジア太平洋
    • 市場動向
    • 市場予測
  • ラテンアメリカ
    • 市場動向
    • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場予測

第9章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BioLife Solutions, Inc.
    • Thermo Fisher Scientific Inc.
    • VWR International, LLC
    • Panasonic Corporation
    • BioCision LLC
図表

List of Figures

  • Figure 1: Global: Biopreservation Market: Major Drivers and Challenges
  • Figure 2: Global: Biopreservation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biopreservation Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Biopreservation Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Biopreservation Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Biopreservation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Biopreservation Industry: SWOT Analysis
  • Figure 8: Global: Biopreservation Industry: Value Chain Analysis
  • Figure 9: Global: Biopreservation Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Biopreservation Equipment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biopreservation Equipment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biopreservation Media Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biopreservation Media Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biopreservation (Therapeutic Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biopreservation (Therapeutic Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biopreservation (Biobank Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biopreservation (Biobank Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biopreservation (Drug Discovery Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biopreservation (Drug Discovery Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: North America: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: North America: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Europe: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Europe: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Asia Pacific: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Asia Pacific: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Latin America: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Latin America: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Biopreservation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Biopreservation Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Biopreservation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Biopreservation Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Biopreservation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Biopreservation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Biopreservation Market: Competitive Structure
  • Table 6: Global: Biopreservation Market: Key Players
目次
Product Code: SR112024A829

Abstract

The global biopreservation market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.3 Billion by 2032, exhibiting a growth rate (CAGR) of 10.4% during 2024-2032. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.

Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.

The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.

Biopreservation Market Trends/Drivers:

Increasing Demand for Biobanking

The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.

Continual Advancements in Regenerative Medicine

Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.

The Expansion of the Biopharmaceutical Industry

The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.

Biopreservation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biopreservation market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on product type and application.

Breakup by Product Type:

Biopreservation Equipment

Biopreservation Media

Biopreservation equipment dominates the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes equipment and media. According to the report, biopreservation equipment represented the largest segment.

Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.

On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.

Breakup by Application:

Therapeutic Applications

Biobank Applications

Drug Discovery Applications

Biobank applications hold the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes therapeutic applications, biobank applications, and drug discovery applications. According to the report, biobank applications accounted for the largest market share.

Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.

On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.

Breakup by Region:

North America

Asia Pacific

Europe

Latin America

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.

North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.

Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.

On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.

Competitive Landscape:

Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

BioLife Solutions, Inc.

Thermo Fisher Scientific Inc.

VWR International, LLC

Panasonic Corporation

BioCision LLC

Recent Developments:

In June 2023, BioLife Solutions, Inc. introduced a new, large-capacity controlled-rate freezer (CRF) in order to expand its CRF product line. This new product will allow the company to support autologous and allogeneic CGT customers and its commercial-scale manufacturing as well as fulfills crucial customer needs to perform high-volume cell therapies.

In Jan 2023, Thermo Fisher Scientific Inc. completed its mergers and acquisition (M&A) agreement with The Binding Site Group ("The Binding Site"), a global leader in specialty diagnostics in order to expand its existing specialty diagnostics portfolio and include pioneering innovation in diagnostics and monitoring for multiple myeloma.

PHC Holdings Corporation announced in 2023 that it has acquired the remaining 30% stake in its subsidiary SciMed (Asia) Pte. Ltd., making SciMed a wholly owned subsidiary of PHCHD. This acquisition will assist in expanding the life sciences business of the company across the Asia-Pacific region.

Key Questions Answered in This Report

  • 1. What was the size of the global biopreservation market in 2023?
  • 2. What is the expected growth rate of the global biopreservation market during 2024-2032?
  • 3. What are the key factors driving the global biopreservation market?
  • 4. What has been the impact of COVID-19 on the global biopreservation market?
  • 5. What is the breakup of the global biopreservation market based on the product type?
  • 6. What is the breakup of the global biopreservation market based on the application?
  • 7. What are the key regions in the global biopreservation market?
  • 8. Who are the key players/companies in the global biopreservation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biopreservation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product Type
  • 5.5 Market Breakup by Application
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Product Type

  • 6.1 Biopreservation Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biopreservation Media
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Applications
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biobank Applications
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Discovery Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Competitive Landscape

  • 9.1 Market Structure
  • 9.2 Key Players
  • 9.3 Profiles of Key Players
    • 9.3.1 BioLife Solutions, Inc.
    • 9.3.2 Thermo Fisher Scientific Inc.
    • 9.3.3 VWR International, LLC
    • 9.3.4 Panasonic Corporation
    • 9.3.5 BioCision LLC